Details for New Drug Application (NDA): 022567
✉ Email this page to a colleague
The generic ingredient in VIIBRYD is vilazodone hydrochloride. There are fourteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the vilazodone hydrochloride profile page.
Summary for 022567
Tradename: | VIIBRYD |
Applicant: | Abbvie |
Ingredient: | vilazodone hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 022567
Suppliers and Packaging for NDA: 022567
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VIIBRYD | vilazodone hydrochloride | TABLET;ORAL | 022567 | NDA | Allergan, Inc. | 0456-1110 | 0456-1110-30 | 30 TABLET in 1 BOTTLE (0456-1110-30) |
VIIBRYD | vilazodone hydrochloride | TABLET;ORAL | 022567 | NDA | Allergan, Inc. | 0456-1120 | 0456-1120-30 | 30 TABLET in 1 BOTTLE (0456-1120-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Jan 21, 2011 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Jan 21, 2011 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
Approval Date: | Jan 21, 2011 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 022567
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | VIIBRYD | vilazodone hydrochloride | TABLET;ORAL | 022567-001 | Jan 21, 2011 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | VIIBRYD | vilazodone hydrochloride | TABLET;ORAL | 022567-003 | Jan 21, 2011 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | VIIBRYD | vilazodone hydrochloride | TABLET;ORAL | 022567-002 | Jan 21, 2011 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription